ARAVIS VENTURES
Aravis is the first independent Swiss on-shore private equity house, an established investor in the renewable energy and life science spaces. We are a "hands-on" investor taking leading positions and understanding the balance between finance, commercial assets and people. With this distinct and crafted approach, we are serving over 30 leading investors including corporates, pension funds, government funds, insurance companies and family offices. Currently actively managing more than a quarte... r of a billion Swiss francs, we have a cumulative history of investments in over 100 companies. These have resulted in several noticeable exits including the divestment of several renewable energy companies and a number of life science reverse take-overs, listings and trade sales. Our many years of experience in the Swiss fund industry have enabled us to establish a platform with a comprehensive offering of investment, accounting, regulatory and reporting expertise. Located in Zurich, Aravis was founded in 2001.
ARAVIS VENTURES
Industry:
Biotechnology Energy Life Science Renewable Energy
Founded:
2001-01-01
Status:
Active
Contact:
+41 43 499 2000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics
Similar Organizations
AMS INDUSTRIES
AMS Industries was a private equity firm that used to invest in the energy and industrial sectors.
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Korkia
Korkia is a private equity firm that makes investments in renewable energy and clean tech sectors.
Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-03-27 | Bird Rock Bio | Aravis Ventures investment in Series B - Bird Rock Bio | 15 M USD |
| 2014-02-18 | Synaffix BV | Aravis Ventures investment in Series A - Synaffix BV | N/A |
| 2013-12-26 | Bellerophon Therapeutics | Aravis Ventures investment in Series A - Bellerophon Therapeutics | 80 M USD |
| 2013-12-02 | Telormedix | Aravis Ventures investment in Series B - Telormedix | 6.16 M EUR |
| 2012-01-25 | Telormedix | Aravis Ventures investment in Series B - Telormedix | 6 M CHF |
| 2010-10-12 | Synosia Therapeutics | Aravis Ventures investment in Series C - Synosia Therapeutics | 30 M USD |
| 2010-10-11 | MerLion Pharma | Aravis Ventures investment in Series C - MerLion Pharma | 7 M USD |
| 2009-12-11 | Evolva | Aravis Ventures investment in Post-IPO Equity - Evolva | 27.5 M USD |
| 2009-10-22 | Evolva | Aravis Ventures investment in Series B - Evolva | 28 M CHF |
| 2009-07-01 | Symetis | Aravis Ventures investment in Series B - Symetis | 21.3 M USD |